Zytiga/Prednisone plus ADT after Chemohormonal Therapy
The “New England Journal of Medicine” on August 20, 2015, recommended early “Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.” Slightly under two years later that recommendation has changed. On June 3, 2017, it printed the following trial conclusion: “Among men with locally advanced or metastatic prostate cancer, ADT plus abiraterone and prednisolone was associated with significantly higher rates of overall and failure-free survival than ADT alone. (Funded by Cancer Research U.K. and others; STAMPEDE ClinicalTrials.gov number, NCT00268476, and Current Controlled Trials number, ISRCTN78818544.)”. In short, ADT plus Zytiga/Prednisone is now recommended instead of Taxotere, etc. + ADT as the first line of treatment for metastatic PCa.
As some of you know, my husband’s diagnosis was April 15, 2016, and his treatment was based on the 2015 recommendation. The studies resulting in the second hadn’t yet been completed. Some of the side effects of his treatment are bilateral lymphedema, fatigue, muscle loss, gynecomastia, and memory loss. I would say he “fell in the crack” between the two recommendations. I doubt he would have experienced all of those side effects from Zytiga.
My primary question today is whether the fact that a patient had early chemohormonal therapy lessens the overall survival benefit of the 2017 recommended Zytiga/Prednisone + Lupron (or Firmagon). My second question/complaint is that cost of the latter combination varies from manageable to impossible for most patients, i.e. from $22 to $9500 per month! Why, if the evidence of the most effective current treatment is so apparent, must patients and doctors have to try to negotiate a lower price? In short, do only the rich or famous get an extra few years of life?
———
P.S. On a much lighter note a P.S. to Nalakrats. The Cal/Mag tablets arrived yesterday, but they’re nigh unto impossible to swallow! We’ll dissolve them in water and hope for the best. They do have added Phosphorus but chelated isn’t mentioned anywhere.
Here is a link that will give most of us a smile, I hope.
npr.org/sections/health-sho...
P.P.S. Our brother who died of brain cancer (Mayo, 2002), signed off “go well”. “Go better” will have to do for you and for us. Wellness would be swell, but that horizon is likely as much a mirage for those of us in Stage Four as was the view from the Titanic.
Leswell‘ s spouse since 1962–hey, 55 years ago tomorrow. Time to celebrate all of those good years, minus one.